1. 2020
  2. Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET Imaging

    Bridoux, J., Neyt, S., Debie, P., Descamps, B., Devoogdt, N., Cleeren, F., Bormans, G., Broisat, A., Caveliers, V., Xavier, C., Vanhove, C. & Hernot, S., 1 Apr 2020, In : Molecules. 25, 8, 25081838.

    Research output: Contribution to journalArticle

  3. 2019
  4. Human PD-L1 Nanobody For Immuno-PET Imaging: Sites-pecific Radiolabeling Strategies

    Bridoux, J., Broos, K., Lecocq, Q., Crauwels, M., Martin, C., Cleeren, F., Kondrashov, M., Ballet, S., Bormans, G., Schou, M., Elmore, C., Raes, G., Muyldermans, S., Devoogdt, N., Keyaerts, M., Caveliers, V. & Xavier, C., 18 Oct 2019.

    Research output: Unpublished contribution to conferencePoster

  5. Quantification of I-131 activity in mouse kidneys using micro-SPECT and ex vivo gamma counting: experimental evaluation of uncertainties

    Vargas, C. S., Struelens, L., D'Huyvetter, M., Eersels, J. L., Caveliers, V. & Covens, P., Oct 2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, SUPPL 1, p. S483-S483

    Research output: Contribution to journalMeeting abstract (Journal)

  6. Site-specific Radiolabeling Strategies For PET Imaging: Development Of Human PD-L1 Nanobody

    Bridoux, J., Broos, K., Lecocq, Q., Crauwels, M., Martin, C., Cleeren, F., Kondrashov, M., Ballet, S., Bormans, G., Raes, G., Breckpot, K., Muyldermans, S., Schou, M., Elmore, C., Devoogdt, N., Keyaerts, M., Caveliers, V. & Xavier, C., 5 Sep 2019, p. 77.

    Research output: Unpublished contribution to conferencePoster

  7. Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior

    Dekempeneer, Y., Back, T., Aneheim, E., Jensen, H., Puttemans, J., Xavier, C., Keyaerts, M., Palm, S., Albertsson, P., Lahoutte, T., Caveliers, V., Lindegren, S. & D'Huyvetter, M., Aug 2019, In : Molecular Pharmaceutics. 16, 8, p. 3524-3533

    Research output: Contribution to journalArticle

  8. Site-specifically radiolabelled Human PD-L1 Nanobody: a new tool for clinical PET imaging

    Bridoux, J., Broos, K., Crauwels, M., Lecocq, Q., Martin, C., Cleeren, F., Bormans, G., Ballet, S., Raes, G., Breckpot, K., Muyldermans, S., Devoogdt, N., Caveliers, V., Keyaerts, M. & Xavier, C., 26 May 2019.

    Research output: Unpublished contribution to conferencePoster

  9. Poster presentation. Phase II trial of HER2-PET/CT using 68Ga-anti-HER2 VHH1 for characterization of HER2 presence in brain metastases of breast cancer patients

    Keyaerts, M., Xavier, C., Everaert, H., Vaneycken, I., Fontaine, C., Decoster, L., Vanhoeij, M., Caveliers, V. & Lahoutte, T., 1 May 2019, In : Annals of Oncology. 30, (suppl_3): iii1-iii26. 10.1093/annonc/mdz095, 85TiP.

    Research output: Contribution to journalMeeting abstract (Journal)

  10. Site-specifically radiolabelled human PD-L1 nanobody: A new tool for clinical PET imaging

    Bridoux, J., Broos, K., Crauwels, M., Lecocq, Q., Martin, C., Cleeren, F., Bormans, G., Ballet, S., Raes, G., Breckpot, K., Muyldermans, S., Devoogdt, N., Caveliers, V., Keyaerts, M. & Xavier, C., May 2019, In : Journal of Labelled Compounds & Radiopharmaceuticals. 62, p. S456-S457

    Research output: Contribution to journalMeeting abstract (Journal)

Previous 1 2 3 4 5 6 7 8 ...21 Next

ID: 157891